Young James Emmett insider trades
Young James Emmett has filed 4 Form 4s with the SEC that we hold, all for TriSalus Life Sciences, Inc. (TLSI), as Chief Financial Officer. Across all of them we count 2 purchases worth $163.5K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 24,000 shares of TriSalus Life Sciences, Inc. worth $129.6K, dated 2025-01-27. The first filing on our record is dated 2025-01-29 and the latest 2025-05-21.
TriSalus Life Sciences, Inc. (TLSI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-01-27 | P, purchase reported on Form 4 | 24,000 | $129.6K | 2025-01-29 |
| 2025-02-05 | P, purchase reported on Form 4 | 6,000 | $33.9K | 2025-02-06 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2050748) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms